Publications
Funding Health and Social Care in Montreal, Quebec: A Review of the Methods and the Potential Role of Incentives. Ottawa: Canadian Foundation for Healthcare Improvement; 2013.
Growth in private payments for health care by Canadian households. Health Policy. 2013.
Here today, gone tomorrow: The issue attention cycle and national print media coverage of prescription drug financing in Canada. Health Policy. 2013.
Inter-jurisdictional cooperation on pharmaceutical product listing agreements: views from Canadian provinces. BMC Health Services Research. 2013;13(34).
Measuring Patient Experiences in Primary Health Care: A review and classification of items and scales used in publicly-available questionnaires. Vancouver: Centre for Health Services and Policy Research; 2013.
Money Left on the Table: Generic Drug Prices in Canada. Healthcare Policy. 2013;8(3):25.
Pharmaceutical Sales Representatives and Patient Safety: A Comparative Prospective Study of Information Quality in Canada, France and the United States. Journal of General Internal Medicine. 2013.
What, If Anything, Does Amenable Mortality Tell Us about Regional Health System Performance? Healthcare Policy. 2013;8(3):79-91.
Bundles: An opportunity to align incentives for continuing care in Canada? Health Policy. 2012.
Designation, diligence and drift: understanding laboratory expenditure increases in British Columbia, 1996/97 to 2005/06. BMC Health Services Research. 2012;12.
The effect of cost on adherence to prescription medications in Canada. CMAJ. 2012;184(3):297-302.
Fraser Health: Healthcare Spending Quantum Analysis. Ottawa: Canadian Foundation for Healthcare Improvement; 2012.
The importance of measuring strength-of-preference scores for health care options in preference-sensitive care. Journal of Clinical Epidemiology. 2012.
Independent pharmacist prescribing in Canada. Canadian Pharmacists Journal. 2012;145(1):17-23.
Information behaviour of Canadian pharmaceutical policy makers. Health Information and Libraries Journal. 2012;29(1):16-27.
Prescription drug use in pregnancy: a retrospective, population-based study in british columbia, Canada (2001-2006). Clinical Therapeutics. 2012;34(1):239-249.e2.
The Public Provision of Pharmaceuticals: A Synthesis of Policies in Ten Developed Countries. Vancouver, BC: Pharmaceutical Policy Research Collaboration; 2012.
Reviewing the Potential Roles of Financial Incentives for Funding Healthcare in Canada. Ottawa: Canadian Foundation for Healthcare Improvement; 2012.
The Road to Competitive Generic Drug Prices in Canada. CMAJ. 2012;Online first.
Stitching the gaps in the Canadian public drug coverage patchwork?: a review of provincial pharmacare policy changes from 2000 to 2010. Health Policy. 2012;104(1):19-26.
Who Uses Assisted Living in British Columbia? An Initial Exploration. Vancouver(BC): UBC Centre for Health Services and Policy Research; 2012.
British Columbia Hospitals: Examination and Assessment of Payment Reform. BMC Health Services Research. 2011;11(1):150.
British Columbia hospitals: examination and assessment of payment reform (B-CHeaPR). BMC Health Services Research. 2011;11:150.
The cost of drug development: a systematic review. Health Policy. 2011;100(1):4-17.
Despite law, fewer than one in eight completed studies of drugs and biologics are reported on time on ClinicalTrials.gov. Health Affairs. 2011;30(12):2338-2345.
